integration of early palliative care in the management of metastatic upper gastrointestinal (GI) cancers has been proposed to improve patient outcomes by addressing symptom burden and enhancing quality of life…
Introduction: Colorectal cancers (CRC) are diagnosed through the two-week-wait lower GI cancer referral pathway. Anemia can be a sign of occult GI bleeding and may indicate sinister pathology ... microcytic anemia. Only…
Many somatic mutations have been detected in GI cancers, leading to the identification of some key drivers of disease progression, but the involvement of large genomic rearrangements has often been
long-term association between four dietary quality indices and the risk of gastrointestinal (GI) cancer. x Baseline details of the dietary intake of participants, assessed by a single food frequency ... diet quality…
risk. To systematically review available evidence on lifestyle and substance use factors associated with GI cancers in Northeast India, with emphasis on indigenous populations of Arunachal Pradesh. Methods: Following…
incidence of malnutrition in patients with gastrointestinal (GI) cancer is high, preoperative nutritional support can effectively improve the clinical outcomes. However, due to various factors, preoperative nutritional…
recent years, considerable progress has been made in understanding the molecular pathogenesis of GI cancers, leading to the development of targeted therapies and immunotherapies that hold promise for improved patient…
subjects either sex out of which 35 normal adults and 105 gastrointestinal (GI) cancer patients. The follow up study was further undertaken and values of serum ... after surgery. Serum Zn level was found significantly…
years) between initial asbestos exposure and exhibition of disease. However, the gastrointestinal (GI) cancers resulting from asbestos exposure are not as clearly defined. In this review, we summarize some…
number of Gastrointestinal (GI) cancer patients in Malaysia is rising. Caregivers need to perform their responsibilities as they spend most of their time providing care for the patient in their ... study used Rasch…
Carcinoembryonic Antigen (CEA) is one of the most widely investigated tumor markers in gastrointestinal (GI) cancers. Estimation of circulating tumor markers is a non- invasive quantitative method. Serum levels…
first course of treatment at Winthrop. Winthrop breast cancer, lung cancer, prostate cancer, colorectal / GI cancer, bladder cancers account for over half of all cancers seen at Winthrop thereby creating
factors, mainly n-3 fatty acids (FA) might affect survival days of patients with GI cancers. Methods: All consecutive patients with GI cancers admitted between December 2012 and September ... values might show invert…
incidence of malnutrition in patients with gastrointestinal (GI) cancer is high, preoperative nutritional support can effectively improve the clinical outcomes. However, due to various factors, preoperative nutritional…
undergoing gastrointestinal tumour surgery, although surgical resection is still the main treatment for gastrointestinal (GI) cancer. This meta-analysis intends to investigate the effectiveness of n-3 PUFAs on…
cancer cases and causing 22.7% of all cancer related deaths. In Tanzania the GIT cancer incidences are steadily increasing significantly like any other less developed countries. Most of the risk ... cases. Conclusion…
concept is not universally applicable. Irrespective, the role of the CSCs in gastrointestinal (GI) cancers, responsible for the most cancer-associated death, has been widely accepted and appreciated. However, despite…
were preferred in GI tumors (p=0.014). Within DOACs, rivaroxaban use was higher with GI cancers and apixaban was prescribed more often in GU malignancies (p=0.00049). Anticoagulated associated bleeding ... events in GI…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.